Clinical Trials on Bacterium; Agent in Belgium

Total 215 results

Université Catholique de Louvain

Recruiting

Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units (Pop-PK/PD)

Pharmacokinetics | Infection | Infection, Bacterial | Anti-Bacterial Agents | Drug Monitoring | Infections, Respiratory

Belgium
Paul M. Tulkens

Recruiting

Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients (TEMODELTA)

Pharmacokinetics | Infection | Infections, Bacterial | Drug Monitoring | Antibacterial Agents | Temocillin

Belgium
Erasme University Hospital

Recruiting

Management of Neuromuscular Blocking Agents and Their Antagonism (NMBA_periop)

Neuromuscular Monitoring | Neuromuscular Blocking Agents

Belgium
Universitair Ziekenhuis Brussel
University Ghent; Vrije Universiteit Brussel

Not yet recruiting

Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. (PABTOX)

Breast Cancer | Body Weight | Chemotherapeutic Toxicity | Physical Inactivity | Chemotherapeutic Agent Toxicity | Paclitaxel Adverse Reaction

Belgium
Jules Bordet Institute
Université Libre de Bruxelles; Fondation Kisane; Les Amis de l'Institut

Unknown

A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting (MADESIO)

Adults | Hematological Malignancy | Oral Antineoplastic Agents

Belgium
Hellenic Institute for the Study of Sepsis
European Commission

Completed

Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System (INCLASS)

Pneumonia | Sepsis | Mortality | Biomarkers | Respiratory Distress Syndrome | Multiple Organ Failure | Gram-Negative Bacteria Infection

Greece, Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

Gram-Positive Bacterial Infections

Belgium
The University of Queensland

Unknown

Screening Anti-Fungal Exposure in Intensive Care Units (SAFE-ICU)

Antifungal Agents

Belgium, Spain, Finland, United States, Australia, Canada, France, Greece, Hong Kong, Italy, Malaysia, Netherlands, Portugal
University Ghent
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System.

Bacterial Vaginosis

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Clostridium Infections

Belgium
Bert Vaes

Recruiting

The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage

Pneumococcal Infections

Belgium
GlaxoSmithKline

Completed

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Streptococcus Agalactiae | Bacterial Infection Due to Streptococcus, Group B

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Tuberculosis

Belgium
Minervax ApS
Iqvia Pty Ltd

Active, not recruiting

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Group B Streptococcal Infections

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults

Pneumococcal Disease

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
GlaxoSmithKline

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Infections, Meningococcal

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Infections, Meningococcal

Belgium
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Tuberculosis

Belgium
University Ghent

Completed

Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis (LACRING01)

Vaginosis, Bacterial

Belgium
GlaxoSmithKline

Completed

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Prophylactic Pneumococcal Diseases

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
Institute of Tropical Medicine, Belgium

Completed

Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea (ResistAZM)

Neisseria Gonorrhoeae

Belgium
GlaxoSmithKline

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
MJM Bonten
Paris 12 Val de Marne University

Completed

Ecological Effects of Decolonisation Strategies in Intensive Care (RGNOSIS)

ICU-ecology (Multidrug Resistant Bacteria) | ICU-acquired Bacteraemia

Belgium, Spain, United Kingdom, Italy, Portugal, Slovenia
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
Institute of Tropical Medicine, Belgium
University Hospital, Antwerp

Completed

Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection (SeTPAT)

Syphilis

Belgium
University Hospital, Ghent

Recruiting

Antibiotic Dosing in Geriatric Patients at the Emergency Department (AGED)

Frail Elderly Syndrome | Frailty | Infection, Bacterial | Elderly Infection

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections

Infective Endocarditis | Necrotizing Fasciitis

Belgium
Institute of Tropical Medicine, Belgium
Novosanis NV

Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (Colli-Pee)

Sexually Transmitted Diseases, Bacterial

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia

Staphylococcus Aureus Bacteraemia

Belgium
Novartis

Completed

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Typhoid Fever

Belgium
Erasme University Hospital

Completed

Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Staphylococcus Aureus | Staphylococcal Infection | Methicillin Resistance

Belgium
Sciensano
Merck Sharp & Dohme LLC; Pfizer; Universitaire Ziekenhuizen KU Leuven

Recruiting

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium (STREPTO)

Pneumonia | Otitis Media | Sinusitis Bacterial

Belgium
GlaxoSmithKline

Completed

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Whooping Cough

Belgium
GlaxoSmithKline

Completed

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Belgium
University Hospital, Ghent
Research Foundation Flanders

Recruiting

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) With Donor Microbiota (FMT) (DEKODON)

Resistance Bacterial

Belgium
University Hospital, Ghent

Recruiting

Rapid Antimicrobial Susceptibility Testing With MIC Directly From Positive Blood Cultures With ASTar (RASTA)

Bacteremia

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis

Pulmonary Tuberculosis

Belgium
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Typhoid Fever

Belgium
Novartis

Completed

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Typhoid Fever

Belgium
Novartis

Completed

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Pertussis

Belgium
Centre Hospitalier Universitaire Saint Pierre
Université Libre de Bruxelles

Not yet recruiting

Maternal Determinants of Infant Immunity to Pertussis (MADI-02)

Pertussis | Maternal-Fetal Relations | Vaccination; Infection | Immunoglobulins

Belgium
Universiteit Antwerpen
University Hospital, Antwerp; Research Foundation Flanders; Université Libre...

Active, not recruiting

Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants (MAMA)

Pertussis

Belgium
GlaxoSmithKline

Completed

A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays

Infections, Streptococcal

Belgium
Dr Philippe CLEVENBERGH

Completed

Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.

Legionnaires' Disease

Belgium
Erasme University Hospital

Completed

Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure

Bacterial Infections and Mycoses | Liver Disease

Belgium
European Organisation for Research and Treatment...

Terminated

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Head and Neck Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

Spain, France, Belgium, Italy, United Kingdom, Turkey

Clinical Trials on Bacterium; Agent in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations